Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol

British Journal of Haematology

Volumn 158, Issue 4, 2012, Pages 506-514

  Thyagu, Santhosh ^a   Minden, Mark D ^a   Gupta, Vikas ^a   Yee, Karen W L ^a   Schimmer, Aaron D ^a   Schuh, Andre C ^a   Lipton, Jeffrey H ^a   Messner, Hans A ^a   Xu, Wei ^a   Brandwein, Joseph M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy; Haematopoietic stem cell transplantation; Leukaemia; Tyrosine kinase inhibitors

Indexed keywords

ALEMTUZUMAB; ALENDRONIC ACID; ANTIBIOTIC AGENT; ASPARAGINASE; BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CALCIUM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; FLUDARABINE; HYDROCORTISONE; IMATINIB; MERCAPTOPURINE; METHOTREXATE; PENTAMIDINE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISEDRONIC ACID; VINBLASTINE; VINCRISTINE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BEDTIME DOSAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; DECONDITIONING SYNDROME; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ILEUS; INFECTION; INFECTION PREVENTION; LIVER FUNCTION TEST; LUMBAR PUNCTURE; LUNG EMBOLISM; MALE; MYCOSIS; MYELOABLATIVE CONDITIONING; MYOPATHY; NEUROPATHY; NEUTROPENIA; NEUTROPHIL COUNT; OSTEOPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREATITIS; PERIPHERAL NEUROPATHY; PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA; PHILADELPHIA CHROMOSOME POSITIVE CELL; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; REDUCED INTENSITY CONDITIONING; SIDE EFFECT; TREATMENT RESPONSE; VEIN THROMBOSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864297804     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09182.x     Document Type: Article

References (27)

1. Artz, A.S., Pollyea, D.A., Kocherginsky, M., Stock, W., Rich, E., Odenike, O., Zimmerman, T., Smith, S., Godley, L., Thirman, M., Daugherty, C. & Extermann, M. (2006) Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 12, 954-964.
2. Bassan, R., Rossi, G., Pogliani, E.M., Di Bona, E., Angelucci, E., Cavattoni, I., Lambertenghi-Deliliers, G., Mannelli, F., Levis, A., Ciceri, F., Mattei, D., Borlenghi, E., Terruzzi, E., Borghero, C., Romani, C., Spinelli, O., Tosi, M., Oldani, E., Intermesoli, T. & Rambaldi, A. (2010) Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. Journal of Clinical Oncology, 28, 3644-3652.
3. Deeg, H.J. & Sandmaier, B.M. (2010) Who is fit for allogeneic transplantation? Blood, 116, 4762-4770.
4. Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, F., Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, P., Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lhéritier, V., Espérou, H., MacIntyre, E., Vernant, J.P. & Fière, D., Groupe d'Etude et de Traitment de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group). (2002) Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter LALA-94 trial. Blood, 100, 2357-2366.
5. Duckett, D.R. & Cameron, M.D. (2010) Metabolism considerations for kinase inhibitors in cancer treatment. Expert Opinion on Drug Metabolism and Toxicology, 6, 1175-1193.
6. Faderl, S., O'Brien, S., Pui, C.H., Stock, W., Wetzler, M., Hoelzer, D. & Kantarjian, H.M. (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer, 116, 1165-1176.
7. Fielding, A.K. (2010) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica, 95, 8-12.
8. Fielding, A.K. (2011) Philadelphia-positive acute lymphoblastic leukemia-is bone marrow transplant still necessary? Biology of Blood and Marrow Transplantation, 17, S84-S88.
9. Foa, R. (2011) Acute lymphoblastic leukemia: age and biology. Pediatric Reports, 3 Suppl. 2, e2.
10. Foa, R., Vitale, A., Vignetti, M., Meloni, G., Guarini, A., De Proopris, M.S., Elia, L., Paoloni, F., Fazi, P., Climino, G., Nobile, F., Ferrara, F., Castagnola, C., Sica, S., Leoni, P., Zuffa, E., Fozza, C., Luppi, M., Candoni, A., lacobucci, I, Soverini, S., Mandelli, F., Martinelli, G. & Baccarani, M., GIMEMA Acute Leukemia Working Party. (2011) Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 118, 6521-6528.
11. Green, H., Skoglund, K., Rommel, F., Mirghani, R.A. & Lotfi, K. (2010) CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity. European Journal of Clinical Pharmacology, 66, 383-386.
12. Guilfoyle, R., Demers, A., Bredeson, C., Richardsono, E., Rubinger, M., Szwajcer, D. & Seftel, M.D. (2009) Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center. Bone Marrow Transplantation, 43, 133-139.
13. Hughes, T., Deininger, M., Hochhaus, A., Branford, S., Radich, J., Kaeda, J., Baccarani, M., Cortes, J., Nicholas, C.P.C., Brian, J.D., Gabert, J., Grimwade, D., Hehlmann, R., Kamel-Reid, S., Jeffrey, H.L., Longtine, J., Martinelli, G., Saglio, G., Soverini, S. & Stock, W., John, M.G. (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006, 108, 2, 8-37.
14. Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., Vernant, J.P., Lafage-Pochitaloff, M., Chassevent, A., Lhéritier, V., Macintyre, E., Béné, M.C., Ifrah, N. & Dombret, H. (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. Journal of Clinical Oncology, 27, 911-918.
15. de Labarthe, A., Rousselot, P., Huguet-Rigal, F., Delabesse, E., Witz, F., Maury, S., Réa, D., Cayuela, J.M., Vekemans, M.C., Reman, O., Buzyn, A., Pigneux, A., Escoffre, M., Chalandon, Y., MacIntyre, E., Lhéritier, V., Vernant, J.P., Thomas, X., Ifrah, N. & Dombret, H., Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). (2007) Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. Blood, 109, 1408-1413.
16. Lee, K.H., Lee, J.H., Choi, S.J., Lee, J.H., Seol, M., Lee, Y.S., Kim, W.K., Lee, S.J., Seo, E.J., Jang, S., Park, C.J. & Chi, H.S. (2005) Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia, 19, 1509-1516.
17. Nebot, N., Crettol, S., d'Esposito, F., Tattam, B., Hibbs, D.E. & Murray, M. (2010) Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. British Journal of Pharmacology, 161, 1059-1069.
18. Ribera, J.M., Oriol, A., González, M., Vidriales, B., Brunet, S., Esteve, J., Del Potro, E., Rivas, C., Moreno, M.J., Tormo, M., Martin-Reina, V., Sarrá, J., Parody, R., de Oteyza, J.P., Bureo, E. & Bernal, M.T., Programa Español de Tratamiento en Hematología; Grupo Espanol de Trasplante Hemopoyetico Groups. (2010) Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica, 95, 87-95.
19. Rowe, J.M. (2011) Interpreting data on transplant selection and outcome in adult acute lymphoblastic leukemia (ALL). Biology of Blood and Marrow Transplantation, 17, S76-S83.
20. Sorror, M.L., Maris, M.B., Storb, R., Baron, F., Sandmaier, B.M., Maloney, D.G. & Storer, B. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood, 106, 2912-2919.
21. Stock, W., La, M., Sanford, B., Bloomfield, C.D., Vardiman, J.W., Gaynon, P., Larson, R.A. & Nachman, J., Children's Cancer Grouop; Cancer and Leukemia Group B studies. (2008) What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood, 112, 1646-1654.
22. Storring, J.M., Minden, M.D., Kao, S., Gupta, V., Schuh, A.C., Schimmer, A.D., Yee, K.W., Kamel-Reid, S., Chang, H., Lipton, J.H., Messner, H.A., Xu, W. & Brandwein, J.M. (2009) Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. British Journal of Haematology, 146, 76-85.
23. Thomas, D.A., Faderl, S., Cortes, J., O'Brien, S., Giles, F.J., Kornblau, S.M., Garcia-Manero, G., Keating, M.J., Andreeff, M., Jeha, S., Beran, M., Verstovsek, S., Pierce, S., Letvak, L., Salvado, A., Champlin, R., Talpaz, M. & Kantarjian, H. (2004) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood, 103, 4396-4407.
24. Vignetti, M., Fazi, P., Cimino, G., Marinelli, G., Di Raimondo, F., Ferrara, F., Meloni, G., Ambrosetti, A., Quarta, G., Pagano, L., rege-Cambrin, G., Elia, L., Bertieri, R., Annino, L., Foà, R., Baccarani, M. & Mandelli, F. (2007) Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood, 109, 3676-3678.
25. Wassmann, B., Pfeifer, H., Goekbuget, N., Beelen, D.W., Beck, J., Stelljes, M., Bornhäuser, M., Reichle, A., Perz, J., Haas, R., Ganser, A., Schmid, M., Kanz, L., Lenz, G., Kaufmann, M., Binckebanck, A., Brük, P., Reutzel, R., Gschaidmeier, H., Schwartz, S., Hoelzer, D. & Ottmann, O.G. (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood, 108, 1469-1477.
26. Xhaard, A., Porcher, R., Chien, J.W., de Latour, R.P., Robin, M., Ribaud, P., rocha, V., Devergie, A., Ferry, C., Martin, P.J. & Socié, G. (2008) Impact of comorbidity indexes on non-relapse mortality. Leukemia, 22, 2062-2069.
27. Yanada, M., Takeuchi, J., Sugiura, I., Akiyama, H., Usui, N., Yagasaki, F., Kobayashi, T., Ueda, Y., Takeuchi, M., Miyawaki, S., Maruta, A., Emi, N., Miyazaki, Y., Ohtake, S., Jinnai, I., Matsuo, K., Naoe, T. & Ohno, R., Japan Adult Leukemia Study Group. (2006) High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. Journal of Clinical Oncology, 24, 460-466.